Investigating how certain enzymes produce natural compounds.
Alkaloid Biosynthetic Studies
This study is looking at how certain enzymes help create natural compounds called alkaloids, which can lead to new treatments for infections, so it could help patients find better options for their health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University (Charles River Campus) NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10873928 on NIH RePORTER |
What this research studies
This research focuses on understanding how specific non-heme iron enzymes catalyze reactions that are crucial for the production of alkaloids, which are natural compounds with significant biological activities. By examining different enzymatic processes, the researchers aim to uncover the mechanisms behind these reactions, which could lead to the development of new anti-infective agents. Patients may benefit from this research as it could enhance the availability of effective treatments derived from these natural products. The study involves detailed biochemical analyses and computational modeling to explore enzyme functions.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with infections that are resistant to current treatments, as they may benefit from new anti-infective agents developed through this work.
Not a fit: Patients with non-infectious conditions or those not affected by antibiotic-resistant infections may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and more effective anti-infective drugs derived from natural compounds.
How similar studies have performed: Previous research has shown promise in utilizing similar enzymatic approaches to develop new therapeutic agents, indicating a potential for success in this area.
Where this research is happening
Boston, United States
- Boston University (Charles River Campus) — Boston, United States (Active)
Researchers
- Principal investigator: Liu, Pinghua — Boston University (Charles River Campus)
- Study coordinator: Liu, Pinghua
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.